Latest News｜Institute for Biotechnology and Medicine Industry│IBMI

Latest News

Date	Subject	Media
2025-09-20	Lin BioScience Subsidiary Belite Completes LBS-008 STGD1 Phase III Trial, Secures NT$8.4 Billion Private Placement	Economic Daily News
2025-09-20	Camcevi Milestone Boosts Foresee Pharmaceuticals’ August Revenue to NT$142 Million, Second-Highest on Record	Commercial Times
2025-09-20	Gongwin Biopharm’s China Market Penetration Boosts August Revenue; PTS302 Targets Expanded Indications	Investor
2025-09-20	IBMI Delegation Arrives in Dubai to Engage Leading Middle Eastern Hospitals and Venture Capital, Opening New Bilateral Collaboration Opportunities	IBMI
2025-09-20	A New Era in Life-Saving Care! AIoT-Powered Integrated Critical Care System Gives Taipei Ambulances a Golden 6-Minute Advantage	China Times
2025-09-20	Daiken Biomedical Lists on the Stock Exchange on September 9, Targets Japanese Market Next Year	Economic Daily News
2025-09-20	ADIMMUNE Production Lines Running at Full Capacity, Partnering with Sanofi and Korean Pharma to Expand Global Markets	Commercial Times
2025-09-20	Taiwanese Traditional Chinese Medicine Goes Global: Exclusive Interview with Yi-Chang Su on “Leading Medicine with Therapeutics, Driving Agriculture with Medicine”	IBMI
2025-09-20	PharmaEssentia Records Second-Highest August Revenue, Submits Taiwan ET Indication Application for Ropeg	Investor
2025-09-20	EirGenix’s Breast Cancer Biosimilar Receives EMA Approval for Post-Marketing Manufacturing Site Change	Economic Daily News

■ Most Watched

■ Industry Watch

■ IBMI News

Information appearing on this website (images and texts, unless otherwise indicated) is the property of IBMI. To use or share, please indicate the source.

Address：9F., No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City , Taiwan (R.O.C.) Contact Number：(02)2655-8168 Fax：(02)2655-7978